Prescription drug · ANDA
Progesterone NDC 51407-981
Progesterone 200 mg/1 · Capsule · Oral · Golden State Medical Supply, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51407-981-01 | 51407098101 | 100 CAPSULE in 1 BOTTLE (51407-981-01)Marketed from Feb 20, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Progesterone
- Generic name (nonproprietary)
- progesterone
- Active ingredients
- Progesterone — 200 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 200900
- Marketing start
- Listing expires
- Other FDA classes
- Progesterone (Chemical structure)
- Identifiers
- Product ID 51407-981_548a0d9d-7647-003b-e063-6394a90af282SPL ID 548a0d9d-7647-003b-e063-6394a90af282SPL set ID 312db3af-9dd2-d5e4-e063-6394a90af999RxCUI 260243, 312641UNII 4G7DS2Q64Y
- Pharmacologic class
- Progesterone
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451407098101followed by a unit qualifier and the quantityPackage 51407-0981-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 200900
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | Golden State Medical Supply, Inc. | 51407-980 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-6771 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-2242 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | Bionpharma Inc. | 69452-148 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | Bionpharma Inc. | 69452-149 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | Proficient Rx LP | 82804-268 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | NuCare Pharmaceuticals,Inc. | 68071-3529 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | Bionpharma Inc. | 69452-233 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | Preferred Pharmaceuticals Inc. | 68788-8709 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | Bionpharma Inc. | 69452-234 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | Preferred Pharmaceuticals Inc. | 68788-8719 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | NuCare Pharmaceuticals,Inc. | 68071-3557 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | REMEDYREPACK INC. | 70518-4166 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-9739 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | Asclemed USA, Inc. | 76420-582 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | Asclemed USA, Inc. | 76420-580 |